ClinicalTrials.Veeva

Menu

Magnesium and Riboflavin Treatment for Post-Concussion Headache

University of Virginia logo

University of Virginia

Status and phase

Enrolling
Phase 2

Conditions

Concussion, Intermediate

Treatments

Drug: magnesium and riboflavin supplement

Study type

Interventional

Funder types

Other

Identifiers

NCT06260072
IRB-HSR 21920

Details and patient eligibility

About

This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.

Enrollment

108 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion;
  • Less than 3 days have elapsed since their injury;
  • Able to swallow capsules

Exclusion criteria

  • Concussion complicated by cranial bleed, skull fracture, additional severe injury;
  • Kidney disfunction or failure;
  • Significant gastro-intestinal dysfunction;
  • Varsity Athlete;
  • Two or more previous concussions;
  • Women who are pregnant or breast feeding;
  • Taking tetracycline, fluoroquinolone, iron digoxin, chlorpromazine or penicillamine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

108 participants in 2 patient groups, including a placebo group

Active study product
Active Comparator group
Description:
400 mg of Magnesium Oxide and 400 mg Riboflavin in capsule formation
Treatment:
Drug: magnesium and riboflavin supplement
Placebo study product
Placebo Comparator group
Description:
Inert placebo in capsule formation
Treatment:
Drug: magnesium and riboflavin supplement

Trial contacts and locations

1

Loading...

Central trial contact

Stephanie Hartman, MD; Karen Ahern, BSN MBA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems